⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23079428 | 0.83 | LMNA (0.33) | — | |
| SCHEMBL18519961 | 0.78 | CHEK1 (0.41) | — | |
| SCHEMBL19864857 | 0.78 | LIMK1 (0.33) | — | |
| SCHEMBL27414536 | 0.73 | KDM4E (0.35) | — | |
| SCHEMBL27404961 | 0.73 | RAB9A (0.30) | — | |
| SCHEMBL23906371 | 0.70 | — | — | |
| SCHEMBL27404798 | 0.70 | ADORA2B (0.34) | — | |
| SCHEMBL10749916 | 0.70 | — | — | |
| SCHEMBL24857964 | 0.69 | NOS3 (0.34) | — | |
| SCHEMBL21610102 | 0.68 | PDXK (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024119117-A1 | MODIFIED 5' CAP FOR MRNA AND METHODS OF USE THEREOF | PRIME MEDICINE, INC. (US) | 2024-06-06 | — | — | WO | disclosed |
| WO-2023183852-A9 | PHOSPHONATE PRODRUGS AND USE THEREOF | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2023-11-23 | — | — | WO | disclosed |